83877-88-7

Basic information

• Product Name: 1-benzyl-3-bromo-4-piperidone hydrobromide
• Synonyms: 1-Benzyl-3-broMo-piperidin-4-one hydrobroMide;4-Piperidinone, 3-broMo-1-(phenylMethyl)-, hydrobroMide;1-benzyl-3-broMopiperidin-4-one HBr salt;1-Benzyl-3-broMo-4-piperidinone hydrobroMide;1-benzyl-3-Bromopiperidin-4-one HBr;1-benzyl-3-bromo-4-piperidone hydrobromide
• CAS NO: 83877-88-7
• Molecular Formula: C12H15Br2NO
• Molecular Weight: 349.0616
• EINECS: 281-157-4
• Mol File: 83877-88-7.mol
• Article Data: 1

Chemical Properties

• Boiling Point: 384.8°C at 760 mmHg
• Flash Point: 186.5°C
• Appearance: /
• Vapor Pressure: 2.11E-06mmHg at 25°C
• CAS DataBase Reference: 1-benzyl-3-bromo-4-piperidone hydrobromide(CAS DataBase Reference)
• NIST Chemistry Reference: 1-benzyl-3-bromo-4-piperidone hydrobromide(83877-88-7)
• EPA Substance Registry System: 1-benzyl-3-bromo-4-piperidone hydrobromide(83877-88-7)

Safety Data

• Hazardous Substances Data: 83877-88-7(Hazardous Substances Data)

Usage

Description

1-benzyl-3-bromo-4-piperidone hydrobromide is a chemical compound derived from piperidone, featuring a benzyl group and a bromine atom in its molecular structure. This heterocyclic compound is known for its unique pharmacological properties and potential applications in the pharmaceutical industry. The hydrobromide salt form of the compound improves its water solubility and bioavailability, making it a promising candidate for drug development.

Uses

Used in Pharmaceutical Industry:
1-benzyl-3-bromo-4-piperidone hydrobromide is used as a potential therapeutic agent for various conditions due to its unique pharmacological properties. The presence of a benzyl group and a bromine atom in its molecular structure contributes to its potential as a drug candidate.
1-benzyl-3-bromo-4-piperidone hydrobromide is used as a compound with improved water solubility and bioavailability in pharmaceutical formulations, thanks to its hydrobromide salt form. This enhances its suitability for drug development and administration.
Research on 1-benzyl-3-bromo-4-piperidone hydrobromide continues to explore its potential applications in the pharmaceutical industry, aiming to develop new drugs that can address various medical conditions.

InChI:InChI=1/C12H14BrNO.BrH/c13-11-9-14(7-6-12(11)15)8-10-4-2-1-3-5-10;/h1-5,11H,6-9H2;1H

Relevant articles and documents

GUANIDINE COMPOUNDS, AND USE THEREOF AS BINDING PARTNERS FOR 5-HT5 RECEPTORS

The invention relates to guanidine compounds of general formula (I), corresponding enantiomeric, diastereomeric, and/or tautomeric forms thereof, and pharmaceutically acceptable salts thereof. The invention further relates to the use of guanidine compounds as binding partners for 5-HT5 receptors in order to treat diseases modulated by 5-HT5 receptor activity, especially treat neurodegenerative and neuropsychiatric disorders and the signs, symptoms, and malfunctions associated therewith.